The prognostic utility of dynamic risk stratification at disease progression in patients with multiple myeloma

The prognostic utility of dynamic risk stratification at disease progression in patients with multiple myeloma

ABSTRACTObjectives: There may be a shift in risk stratification at progression compared to that at diagnosis in patients with multiple myeloma (MM). We aimed to evaluate whether re-staging and stage migration is of prognostic impact.Methods: Real-world data from the National Longitudinal Cohort of H...

Full description

Bibliographic Details
Main Authors:	Huihsou Fan, Wenqiang Yan, Lingna Li, Jingyu Xu, Jiahui Liu, Yan Xu, Weiwei Sui, Shuhui Deng, Chenxing Du, Shuhua Yi, Dehui Zou, Lugui Qiu, Gang An
Format:	Article
Language:	English
Published:	Taylor & Francis Group 2023-12-01
Series:	Hematology
Subjects:	Multiple myeloma dynamic risk stratification staging re-staging prognostic utility
Online Access:	https://www.tandfonline.com/doi/10.1080/16078454.2023.2182156

Similar Items

Application of clinical nomograms to predicting overall survival and event-free survival in multiple myeloma patients: Visualization tools for prognostic stratification
by: Jiaxuan Xu, et al.
Published: (2022-10-01)

The age-dependent changes in risk weights of the prognostic factors for multiple myeloma
by: Chenxing Du, et al.
Published: (2023-12-01)

Risk Stratification and Treatment in Smoldering Multiple Myeloma
by: Tyler Lussier, et al.
Published: (2021-12-01)

Real-World Data on Clinical Features, Outcomes, and Prognostic Factors in Multiple Myeloma from Miyazaki Prefecture, Japan
by: Keiichi Akizuki, et al.
Published: (2020-12-01)

Development and Validation of a Novel Prognostic Model for Overall Survival in Newly Diagnosed Multiple Myeloma Integrating Tumor Burden and Comorbidities
by: Shuangshuang Jia, et al.
Published: (2022-03-01)

Dynamic prediction of the risk of recurrence in patients over 60 years of age with differentiated thyroid carcinoma
by: Yanina Jimena Morosán, et al.
Published: (2016-02-01)

Microfluidic enrichment of plasma cells improves treatment of multiple myeloma
by: Yunjing Zeng, et al.
Published: (2018-06-01)

Treatment of Smoldering Multiple Myeloma: Ready for Prime Time?
by: E. Bridget Kim, et al.
Published: (2020-05-01)

Multiple myeloma: five-year experience at a University Hospital
by: Juliana Todaro, et al.
Published: (2011-06-01)

Multiple myeloma: five-year experience at a University Hospital
by: Juliana Todaro, et al.
Published: (2011-06-01)

A novel glycolysis-related gene signature for predicting the prognosis of multiple myeloma
by: Bingxin Zhang, et al.
Published: (2023-06-01)

Prognostic value of the Second Revision of the International Staging System (R2-ISS) in a real-world cohort of patients with newly-diagnosed multiple myeloma
by: Wenqiang Yan, et al.
Published: (2023-07-01)

Relationship of differences in immunoglobulin heavy/light chain pairs (HevyliteTM), selected laboratory parameters and stratification systems in different immunochemical types of multiple myeloma
by: Vlastimil Scudla, et al.
Published: (2016-03-01)

Methodology of a Novel Risk Stratification Algorithm for Patients with Multiple Myeloma in the Relapsed Setting
by: Walter Bouwmeester, et al.
Published: (2019-11-01)

Application of Next-Generation Sequencing for the Genomic Characterization of Patients with Smoldering Myeloma
by: Martina Manzoni, et al.
Published: (2020-05-01)

Composite risk stratification models optimise the value of imaging in prostate cancer staging
by: Tom McAllister, et al.
Published: (2023-09-01)

Socioeconomic status-based survival disparities and nomogram prediction for patients with multiple myeloma: Results from American and Chinese populations
by: Jiaxuan Xu, et al.
Published: (2022-08-01)

Genomics of Smoldering Multiple Myeloma: Time for Clinical Translation of Findings?
by: Marta Lionetti, et al.
Published: (2021-07-01)

Prognostic significance of β2-microglobulin decline index in multiple myeloma
by: Tianyu Zhang, et al.
Published: (2024-03-01)

Impact of the lactate dehydrogenase in association with the International Staging System prognostic score in multiple myeloma patients treated in real life
by: Maricy Almeida Viol Ferreira Lopes, et al.
Published: (2023-04-01)

A retrospective observational study to evaluate the reliability of staging and risk stratification of adolescent and adult patients with Hodgkin's lymphoma registered at the lymphoma clinic of a tertiary cancer center in Western India
by: Ajay Kumar Singh, et al.
Published: (2023-01-01)

Aberrant metabolic processes promote the immunosuppressive microenvironment in multiple myeloma
by: Junqiang Lv, et al.
Published: (2022-11-01)

The significance of prognostic profiling in the treatment of patients with multiple myeloma
by: Mitrović Marko, et al.
Published: (2020-01-01)

Development of a prognostic nomogram and risk stratification system for upper thoracic esophageal squamous cell carcinoma
by: Yu Lin, et al.
Published: (2023-04-01)

Testing Mayo Clinic’s New 20/20/20 Risk Model in Another Cohort of Smoldering Myeloma Patients: A Retrospective Study
by: Camille Tessier, et al.
Published: (2021-05-01)

Establishment and validation of a prognostic nomogram for extrahepatic cholangiocarcinoma
by: Fangrui Zhao, et al.
Published: (2022-11-01)

A gene-based score for the risk stratification of stage IA lung adenocarcinoma
by: Yanlu Xiong, et al.
Published: (2024-01-01)

P910: DOES MINIMAL RESIDUAL DISEASE OF STEM CELL COLLECTION HAVE PROGNOSTIC IMPACT ON PATIENTS WITH MULTIPLE MYELOMA?
by: X. Jingyu, et al.
Published: (2022-06-01)

Social frailty predicts worse outcomes in patients with multiple myeloma: A novelty in an old approach
by: Toshiki Terao, et al.
Published: (2020-07-01)

Using Judgment Post Stratification in Two Stage Cluster Sampling
by: Ali Najafi Majid Abadi, et al.
Published: (2021-09-01)

A stratified therapeutic model incorporated with studies on regulatory B cells for elderly patients with newly diagnosed multiple myeloma
by: Wenjiao Tang, et al.
Published: (2023-02-01)

Research Progress in Risk Stratification Tools and Prognostic Models for Non-muscle-invasive Bladder Cancer
by: ZHAO Jiahong, et al.
Published: (2020-04-01)

Evaluation of Prognostic Significance of the International Staging System According to Glomerular Filtration Rate in Newly Diagnosed Multiple Myeloma Patients Eligible for Autologous Stem Cell Transplantation
by: Rafiye Çiftçiler, et al.
Published: (2021-02-01)

Clinical Diversity of Multiple Myeloma at the First Presentation through the Time Lapse to Diagnosis in Kurdistan Region, Iraq
by: Truska A. Amin, et al.
Published: (2020-12-01)

Experts’ consensus on the definition and management of high risk multiple myeloma
by: Chiara Marcon, et al.
Published: (2023-01-01)

Multiple Myeloma and Kidney Impairment at Diagnosis: A Nephrological Perspective from an Eastern European Country
by: Gabriel Ștefan, et al.
Published: (2023-07-01)

Effects of Amyloid Light-Chain Amyloidosis on Clinical Characteristics and Prognosis in Multiple Myeloma: A Single-Center Retrospective Study
by: Xu J, et al.
Published: (2021-02-01)

Subspecialty Second-Opinion in Multiple Myeloma CT: Emphasis on Clinically Significant Lytic Lesions
by: Alberto Stefano Tagliafico, et al.
Published: (2020-04-01)

Risk stratification of thromboembolic complications development in surgical patients
by: K. I. Popandopulo, et al.
Published: (2020-03-01)

Stratification of Patients With Stage IB NSCLC Based on the 8th Edition of the American Joint Committee on Cancer (AJCC) Staging Manual
by: Lei-Lei Wu, et al.
Published: (2020-04-01)